RISK OF DEATH IN HOSPITALIZED DOGS WITH HEMOSTATIC PROFILE DISORDERS

Bruno Albuquerque de Almeida; Ana Paula Soares Borenstein; Felipe Yuji Okano; Mônica Alejandra Camargo Castillo; Daiani Wissmann; Stella de Faria Valle

doi:10.15210/sah.v8i2.18485

Bruno Albuquerque de Almeida Universidade Federal de Rio Grande do Sul http://orcid.org/0000-0001-5859-6335
Ana Paula Soares Borenstein Universidade Federal do Rio Grande do Sul http://orcid.org/0000-0002-9440-3526
Felipe Yuji Okano Universidade Federal do Rio Grande do Sul http://orcid.org/0000-0001-5462-7763
Mônica Alejandra Camargo Castillo Universidade Federal do Rio Grande do Sul http://orcid.org/0000-0001-9829-9079
Daiani Wissmann Universidade Federal de Santa Maria http://orcid.org/0000-0002-8283-9103
Stella de Faria Valle Universidade Federal do Rio Grande do Sul http://orcid.org/0000-0001-8507-257X

DOI: https://doi.org/10.15210/sah.v8i2.18485

Resumo

Identifying patients who have a higher risk of death is crucial to define appropriate risk classification, treatment and prognosis, which can result in a favorable outcome. The objective of this retrospective study was to evaluate whether the prolongation of prothrombin times, activated partial thromboplastin, and thrombocytopenia are indicators of death risk in hospitalized canine patients. A retrospective study using medical records (2014-2018) of the Laboratory of Veterinary Clinical Analysis at the Federal University of Rio Grande do Sul identified 218 patients. Dogs having a single disorder in laboratory tests did not differ from the control. Groups presenting patients with multiple changes showed three times more death risk than the control group and a cumulative incidence of death higher than 29%.

Downloads

Não há dados estatísticos.